DiaMedica Therapeutics In...

AI Score

0

Unlock

5.78
0.11 (1.94%)
At close: Jan 17, 2025, 3:59 PM
5.71
-1.13%
After-hours Jan 17, 2025, 04:00 PM EST

DiaMedica Therapeutics Statistics

Share Statistics

DiaMedica Therapeutics has 42.76M shares outstanding. The number of shares has increased by 12.65% in one year.

Shares Outstanding 42.76M
Shares Change (YoY) n/a
Shares Change (QoQ) 0.03%
Owned by Institutions (%) n/a
Shares Floating 24.02M
Failed to Deliver (FTD) Shares 3.25K
FTD / Avg. Volume 3.41%

Short Selling Information

The latest short interest is 175.55K, so 0.41% of the outstanding shares have been sold short.

Short Interest 175.55K
Short % of Shares Out 0.41%
Short % of Float 0.73%
Short Ratio (days to cover) 3.88

Valuation Ratios

The PE ratio is -4.77 and the forward PE ratio is -5.82.

PE Ratio -4.77
Forward PE -5.82
PS Ratio 0
Forward PS 4.6
PB Ratio 1.81
P/FCF Ratio -4.93
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for DiaMedica Therapeutics Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 19.27, with a Debt / Equity ratio of 0.01.

Current Ratio 19.27
Quick Ratio 19.27
Debt / Equity 0.01
Total Debt / Capitalization 0.78
Cash Flow / Debt -46.82
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is -0.38% and return on capital (ROIC) is -41.42%.

Return on Equity (ROE) -0.38%
Return on Assets (ROA) -0.36%
Return on Capital (ROIC) -41.42%
Revenue Per Employee 0
Profits Per Employee -1.08M
Employee Count 18
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 43.00K
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by 104.96% in the last 52 weeks. The beta is 1.46, so DiaMedica Therapeutics 's price volatility has been higher than the market average.

Beta 1.46
52-Week Price Change 104.96%
50-Day Moving Average 5.04
200-Day Moving Average 3.83
Relative Strength Index (RSI) 56.88
Average Volume (20 Days) 95.44K

Income Statement

Revenue n/a
Gross Profit -30.00K
Operating Income -21.27M
Net Income -19.38M
EBITDA -19.31M
EBIT n/a
Earnings Per Share (EPS) -0.6
Full Income Statement

Balance Sheet

The company has 4.54M in cash and 400.00K in debt, giving a net cash position of 4.14M.

Cash & Cash Equivalents 4.54M
Total Debt 400.00K
Net Cash 4.14M
Retained Earnings -115.56M
Total Assets 52.52M
Working Capital 46.47M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.73M and capital expenditures -24.00K, giving a free cash flow of -18.75M.

Operating Cash Flow -18.73M
Capital Expenditures -24.00K
Free Cash Flow -18.75M
FCF Per Share -0.58
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

DMAC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -10.38%
FCF Yield -7.59%
Dividend Details

Analyst Forecast

The average price target for DMAC is $7, which is 21.1% higher than the current price. The consensus rating is "Buy".

Price Target $7
Price Target Difference 21.1%
Analyst Consensus Buy
Analyst Count 3
Stock Forecasts

Stock Splits

The last stock split was on Nov 15, 2018. It was a backward split with a ratio of 1:20.

Last Split Date Nov 15, 2018
Split Type backward
Split Ratio 1:20

Scores

Altman Z-Score 24.86
Piotroski F-Score 3